| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 37,860 | 100,390 | 91,500 | 54,520 | 248,120 |
| Sales Growth | -62.29% | +9.72% | +67.83% | -78.03% | +460.09% |
| Net Income | -57,250 | -217,570 | -254,150 | -292,210 | -120,110 |
| Net Income Growth | +73.69% | +14.39% | +13.02% | -143.29% | +62.53% |
2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
2seventy bio Inc. is a cell and gene therapy company. It focuses on the research, development, and commercialization of treatments for cancer. 2seventy bio Inc. is based in Cambridge, Massachusetts.
Fiscal Year End Date: 12/31